Summary
This Form 8-K filing by CVS Health Corporation (CVS) on October 14, 2015, details the early results of its private exchange offers and consent solicitations related to the recently acquired Omnicare, Inc. notes. The company successfully tendered a significant majority of Omnicare's outstanding senior notes for its own newly issued senior notes, with over 96% of the 2022 notes and 98% of the 2024 notes exchanged by the early tender date. This move is a crucial step in integrating Omnicare's debt structure into CVS Health's, simplifying its capital structure and likely reducing borrowing costs. The high participation rate indicates strong investor confidence in CVS Health's creditworthiness and its strategic integration of Omnicare. The company also obtained the necessary consents to amend the terms of the remaining Omnicare notes, eliminating restrictive covenants, which further streamlines its financial obligations.
Key Highlights
- 1CVS Health completed a successful private exchange offer for Omnicare's senior notes, with high participation rates from eligible holders.
- 2Approximately 96.2% of the $400 million in outstanding 4.75% Senior Notes due 2022 issued by Omnicare were tendered.
- 3Approximately 98.2% of the $300 million in outstanding 5.00% Senior Notes due 2024 issued by Omnicare were tendered.
- 4The exchange offered new CVS Health notes (4.75% Senior Notes due 2022 and 5.00% Senior Notes due 2024) in exchange for the Omnicare notes.
- 5CVS Health also successfully solicited consents to amend the terms of the Existing Omnicare Notes, eliminating substantially all restrictive covenants and certain events of default.
- 6The approval of proposed amendments for each series of Omnicare notes was obtained, with consent from holders of a majority of the aggregate principal amount outstanding.
- 7A Registration Rights Agreement was entered into to govern the exchange or registration of the new CVS Health notes.